The history of copyright's flagship drug presents a complex case for stakeholders in the drug sector. While initially a tremendous success, generating huge profits, the intellectual property end and the subsequent entry of off-brand versions have considerably affected revenue. This poses questions about the future profitability of similar drug p… Read More